2nd Quarter - Report
THORN RUN PARTNERS for HARMONY BIOSCIENCES
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to the development of therapies for rare diseases. Issues regarding drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW ROSENBERG | — |
| BEAU SCHUYLER | Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre |
Taxation/Internal Revenue Code TAX
Issues related to the orphan drug tax credit. Issues related to the Prescription Drug User Fee Act (PDUFA). Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW ROSENBERG | — |
| BEAU SCHUYLER | Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.